Predpokladaný rast EPS Q/Q spoločnosti Affimed N.V
Aká je hodnota metriky Predpokladaný rast EPS Q/Q spoločnosti Affimed N.V?
Hodnota metriky Predpokladaný rast EPS Q/Q spoločnosti Affimed N.V. je 5.00%
Aká je definícia metriky Predpokladaný rast EPS Q/Q?
Očakávaný rast EPS (Estimated quarterly EPS growth rate) z roka na rok je predpokladaný rast EPS spoločnosti za ďaľší kvartál v porovnaní s výsledkami z minulého kvartálu.
The prospective EPS growth rate is a predicted estimate of the earnings per share growth rate towards the current quarter and expressed as a percentage compared to the respective past quarter. The estimated earnings per share growth rate is an important factor for judging a company's value. Comparing EPS history with stock price history helps determine the most likely future direction of the stock price.
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
Predpokladaný rast EPS Q/Q spoločností v sektore Health Care sektor na NASDAQ v porovnaní so spoločnosťou Affimed N.V
Čomu sa venuje spoločnosť Affimed N.V?
affimed (symbol: afmd) is a nasdaq-listed clinical-stage biopharmaceutical company focused on discovering and developing targeted immuno-oncology therapies. immuno-oncology represents a highly promising approach to cancer treatment that seeks to harness the body’s own immune defenses to attack and destroy tumor cells. natural killer cells, or nk-cells, and t-cells belong to the most potent cells of the human defense arsenal. affimed’s proprietary, next-generation bispecific antibodies, termed tandabs®, are designed to bring nk-cells or t-cells into close proximity to cancer cells that ultimately triggers a signal cascade that leads to the destruction of cancer cells. due to their novel tetravalent tandem architecture, which provides for four binding domains, the tandabs bind to specific targets on immune and cancer cells with high affinity. in addition, tandabs exhibit kinetic properties allowing the administration as regular intravenous infusion and fine-tuning of dosing. affimed beli
Firmy s metrikou predpokladaný rast eps q/q podobnou spoločnosti Affimed N.V
- Hodnota metriky Predpokladaný rast EPS Q/Q spoločnosti Revlon je 4.80%
- Hodnota metriky Predpokladaný rast EPS Q/Q spoločnosti Time Technoplast je 4.84%
- Hodnota metriky Predpokladaný rast EPS Q/Q spoločnosti Frequency Therapeutics Inc je 4.84%
- Hodnota metriky Predpokladaný rast EPS Q/Q spoločnosti Home Depot je 4.85%
- Hodnota metriky Predpokladaný rast EPS Q/Q spoločnosti Fair Isaac je 4.85%
- Hodnota metriky Predpokladaný rast EPS Q/Q spoločnosti Ameren je 4.85%
- Hodnota metriky Predpokladaný rast EPS Q/Q spoločnosti Affimed N.V je 5.00%
- Hodnota metriky Predpokladaný rast EPS Q/Q spoločnosti Acme United je 5.00%
- Hodnota metriky Predpokladaný rast EPS Q/Q spoločnosti American Tower je 5.05%
- Hodnota metriky Predpokladaný rast EPS Q/Q spoločnosti Silgan je 5.06%
- Hodnota metriky Predpokladaný rast EPS Q/Q spoločnosti K.P.R. Mill je 5.08%
- Hodnota metriky Predpokladaný rast EPS Q/Q spoločnosti Kaveri Seed je 5.08%
- Hodnota metriky Predpokladaný rast EPS Q/Q spoločnosti Golden Entertainment Inc je 5.08%